JP2014507482A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507482A5
JP2014507482A5 JP2013557912A JP2013557912A JP2014507482A5 JP 2014507482 A5 JP2014507482 A5 JP 2014507482A5 JP 2013557912 A JP2013557912 A JP 2013557912A JP 2013557912 A JP2013557912 A JP 2013557912A JP 2014507482 A5 JP2014507482 A5 JP 2014507482A5
Authority
JP
Japan
Prior art keywords
subject
lung
safakutan
bets
msc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013557912A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507482A (ja
JP6204830B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/028524 external-priority patent/WO2012125471A1/en
Publication of JP2014507482A publication Critical patent/JP2014507482A/ja
Publication of JP2014507482A5 publication Critical patent/JP2014507482A5/ja
Application granted granted Critical
Publication of JP6204830B2 publication Critical patent/JP6204830B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013557912A 2011-03-11 2012-03-09 間葉系幹細胞エキソソームに関連する方法および組成物 Active JP6204830B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161451981P 2011-03-11 2011-03-11
US61/451,981 2011-03-11
PCT/US2012/028524 WO2012125471A1 (en) 2011-03-11 2012-03-09 Methods and compositions relating to mesenchymal stem cell exosomes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017168158A Division JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Publications (3)

Publication Number Publication Date
JP2014507482A JP2014507482A (ja) 2014-03-27
JP2014507482A5 true JP2014507482A5 (enExample) 2016-09-01
JP6204830B2 JP6204830B2 (ja) 2017-09-27

Family

ID=45852770

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013557912A Active JP6204830B2 (ja) 2011-03-11 2012-03-09 間葉系幹細胞エキソソームに関連する方法および組成物
JP2017168158A Active JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017168158A Active JP6524162B2 (ja) 2011-03-11 2017-09-01 間葉系幹細胞エキソソームに関連する方法および組成物

Country Status (8)

Country Link
US (3) US9901600B2 (enExample)
EP (1) EP2683389B1 (enExample)
JP (2) JP6204830B2 (enExample)
KR (2) KR101947699B1 (enExample)
CN (2) CN103648509B (enExample)
CA (1) CA2829586C (enExample)
ES (1) ES2629502T3 (enExample)
WO (1) WO2012125471A1 (enExample)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
CN103648509B (zh) * 2011-03-11 2019-02-22 儿童医学中心公司 与间充质干细胞外来体相关的方法和组合物
ITRM20110403A1 (it) * 2011-07-28 2013-01-29 Ospedale Pediatrico Bambino Gesu Microvescicole isolate da cellule mesenchimali come agenti immunosoppressori.
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
GB201202319D0 (en) 2012-02-10 2012-03-28 Orbsen Therapeutics Ltd Stromal stem cells
JP6433896B2 (ja) 2012-08-13 2018-12-05 シーダーズ−サイナイ・メディカル・センターCedars−Sinai Medical Center 組織再生のためのエキソソームおよびマイクロリボ核酸
CN103865873B (zh) * 2012-12-12 2017-04-05 中国医学科学院基础医学研究所 亚全能干细胞分泌的外来体及其应用
EP2931373B1 (en) * 2012-12-12 2019-08-21 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
CA3209023A1 (en) 2013-03-15 2014-09-25 Board Of Regents, The University Of Texas System Mirna biogenesis in exosomes for diagnosis and therapy
EP3003290B1 (en) 2013-06-05 2021-03-10 AgeX Therapeutics, Inc. Compositions for use in the treatment of wounds in mammalian species
ES2909752T3 (es) * 2013-08-01 2022-05-10 Swedish Stromabio Ab MSC en el tratamiento de enfermedades pulmonares inflamatorias
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
CN104694466A (zh) * 2013-12-06 2015-06-10 山西医科大学 间充质干细胞来源的胞外体制备及在急性肺损伤中的应用
JP6343671B2 (ja) * 2013-12-12 2018-06-13 サムスン ライフ パブリック ウェルフェア ファウンデーション トロンビンを利用した幹細胞由来のエキソソームの生成促進方法
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
KR101661847B1 (ko) 2014-03-18 2016-09-30 사회복지법인 삼성생명공익재단 줄기세포 유래 엑소좀을 유효성분으로 포함하는 뇌 염증성 질환의 치료용 조성물
CN106714781B (zh) 2014-05-18 2021-08-10 儿童医学中心公司 涉及外排体的方法和组合物
WO2015191545A1 (en) * 2014-06-09 2015-12-17 University Of Washington Methods of protection against ischemia reperfusion injury
RU2715866C2 (ru) * 2014-06-30 2020-03-03 Тихеникс С.А.У. Мезенхимальные стромальные клетки для лечения синдрома сепсиса
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
EP3209768A1 (en) * 2014-07-25 2017-08-30 Recellerate Inc. Methods of treating exercise-induced pulmonary hemorrhage
CA2962444C (en) 2014-10-03 2023-09-05 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US20170304368A1 (en) * 2014-10-06 2017-10-26 Cedars-Sinai Medical Center Polarization of macrophages to a healing phenotype by cardiosphere-derived cells and by the exosomes secreted by such cells
WO2016072821A1 (ko) * 2014-11-07 2016-05-12 한양대학교 에리카산학협력단 줄기세포 유래 엑소좀을 함유하는 지방세포 분화유도, 지방조직 재생, 피부 미백 또는 주름개선용 조성물
CN118161529A (zh) * 2014-11-07 2024-06-11 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
US20160160181A1 (en) * 2014-12-03 2016-06-09 Capricor Thera[eitocs, Inc. Processes for producing exosomes in reduced oxygen culture conditions
CN104560877B (zh) * 2014-12-18 2017-07-28 福州市传染病医院 一种快速分离细胞外吐小体的方法
CA2972226A1 (en) * 2014-12-24 2016-06-30 Ube Industries, Ltd. Cell culture supernatant fluid derived from lung tissue
US10342830B2 (en) * 2015-01-05 2019-07-09 Gary M. Petrucci Methods and materials for treating lung disorders
US9687511B2 (en) 2015-03-06 2017-06-27 Vivex Biomedical, Inc. Acellular biologic composition and method of manufacture
US11160904B2 (en) * 2017-05-09 2021-11-02 Vivex Biologies Group, Inc. Biological composition in a protectant shroud and methods
US20180325830A1 (en) 2017-05-09 2018-11-15 Vivex Biomedical, Inc. Coated biological composition
KR101566450B1 (ko) * 2015-04-03 2015-11-05 (유)스템메디케어 중간엽 줄기세포에서 단백질의 대량 생산 방법
MX2017013852A (es) 2015-04-28 2019-04-15 Texas A & M Univ Sys Produccion escalable de vesiculas extracelulares estandarizadas, preparaciones de vesiculas extracelular y usos de estos.
WO2016201220A1 (en) * 2015-06-10 2016-12-15 Children's National Medical Center Adipocyte-derived exosomes, and compositions, kits, and methods of using the same for detection and screening
MX2017015962A (es) 2015-06-10 2018-07-06 Univ Texas Uso de exosomas para el tratamiento de enfermedades.
US11123376B2 (en) * 2015-06-12 2021-09-21 Monash University Method of treatment
US11077147B2 (en) * 2015-07-20 2021-08-03 Vivex Biologics Group, Inc. Acellular biologic composition and method of manufacture
CA2993224A1 (en) * 2015-07-31 2017-02-09 Zen-Bio, Inc. Exosome compositions and use thereof for soft tissue repair
CA3007733A1 (en) 2015-12-07 2017-06-15 Biotime, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
US11253551B2 (en) 2016-01-11 2022-02-22 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
EP3922253A1 (en) * 2016-01-15 2021-12-15 Orbsen Therapeutics Limited Sdc-2 exosome compositions and methods of isolation and use
CN109414340B (zh) 2016-01-29 2021-09-10 帕格尼亚医疗公司 用于肺递送的干细胞或干细胞衍生物的雾化
KR101843634B1 (ko) * 2016-04-15 2018-03-30 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
KR20190041456A (ko) * 2016-06-17 2019-04-22 유나이티드 쎄러퓨틱스 코포레이션 향상된 효능을 가진 세포외 소포
US10946047B2 (en) * 2016-06-17 2021-03-16 United Therapeutics Corporation Extracellular vesicles with enhanced potency
KR102464099B1 (ko) * 2016-08-03 2022-11-08 히로시 야부키 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료
US12083149B2 (en) 2016-08-03 2024-09-10 Tohoku University Amelioration and treatment of chronic lung disease using pluripotent stem cells
CN109562129B (zh) * 2016-08-05 2023-02-17 胞外体干细胞株式会社 含有从脂肪来源的干细胞分离的外排体作为活性成分的用于预防或治疗肺纤维化的组合物
US11541078B2 (en) 2016-09-20 2023-01-03 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
CN110072991A (zh) * 2016-10-13 2019-07-30 Vbc控股有限责任公司 来源于发炎的细胞或组织的抗炎外泌体
US20210024893A1 (en) * 2016-10-13 2021-01-28 Vbc Holdings Llc Medical uses of exosomes
CN110520138A (zh) * 2017-02-28 2019-11-29 洛林大学 从华顿氏胶获得的用于治疗脓毒症的间充质干细胞
WO2018187686A1 (en) * 2017-04-07 2018-10-11 StemoniX Inc. Method of manufacturing and purifying exosomes from non-terminally differentiated cells
EP3612191A4 (en) 2017-04-19 2020-12-30 Cedars-Sinai Medical Center METHODS AND COMPOSITIONS FOR TREATING SKELETAL MUSCLE DYSTROPHY
TWI704923B (zh) * 2017-06-26 2020-09-21 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 包含胞外囊泡之製劑、用以製備該製劑之方法及其用途
EP3648777A4 (en) 2017-07-06 2021-04-21 Children's National Medical Center EXOSOMES AND METHODS OF USE
KR20190011213A (ko) * 2017-07-24 2019-02-01 한양대학교 에리카산학협력단 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 골다공증 예방 또는 치료용 조성물
US20220023347A9 (en) * 2017-08-15 2022-01-27 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
US11471559B2 (en) * 2017-11-20 2022-10-18 Vivex Biologics Group, Inc. Bioenergetic bone
US11660355B2 (en) 2017-12-20 2023-05-30 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
US12146137B2 (en) 2018-02-05 2024-11-19 Cedars-Sinai Medical Center Methods for therapeutic use of exosomes and Y-RNAS
CA3098514A1 (en) 2018-04-30 2019-11-14 Children's Medical Center Corporation Mesenchymal stromal cell exosomes and uses thereof
US12031976B2 (en) 2018-05-04 2024-07-09 Samsung Life Public Welfare Foundation Screening method for therapeutic substance for preventing or treating bronchopulmonary dysplasia (BPD)
CA3101971A1 (en) * 2018-05-30 2019-12-05 Direct Biologics Llc A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
JP7363003B2 (ja) * 2018-06-11 2023-10-18 ヘルス、アンド、バイオテック、フランス(アッシュ、アンド、ベー、フランス) 間葉系幹細胞由来細胞外小胞
CN112423768A (zh) * 2018-06-29 2021-02-26 北卡罗来纳州立大学 通过肺球体细胞分泌因子的吸入来进行治疗性肺修复
WO2020023594A1 (en) * 2018-07-24 2020-01-30 Mayo Foundation For Medical Education And Research Compositions and methods involving transforming extracellular vesicles
US12029821B2 (en) * 2018-08-10 2024-07-09 Omnispirant Limited Extracellular vesicles for inhalation
WO2020102684A1 (en) * 2018-11-15 2020-05-22 Washington University Stem cell-derived extracellular vesicles and methods of use thereof
EP3930734A4 (en) * 2019-02-28 2022-12-07 Merakris Therapeutics, LLC EXTRACELLULAR VESICLES DERIVED FROM AMBIENT WATER AND THEIR USES IN WOUND HEALING
JP7372518B2 (ja) * 2019-06-27 2023-11-01 国立大学法人山口大学 骨髄由来間葉系幹細胞の培養方法
US12213995B2 (en) 2019-07-18 2025-02-04 Direct Biologics, Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
US20220273725A1 (en) * 2019-07-31 2022-09-01 Takahiro Ochiya Therapeutic drugs for fibrosis, inflammation, and/or aging diseases
US20210052641A1 (en) * 2019-08-23 2021-02-25 United Therapeutics Corporation Pre-conditioned extracellular vesicles and methods of production
CN110777113B (zh) * 2019-09-10 2021-09-24 中山大学 一种用于日本血吸虫感染治疗的间质干细胞处理方法
KR20220131902A (ko) * 2019-12-04 2022-09-29 유나이티드 쎄러퓨틱스 코포레이션 세포외 소포 및 이의 용도
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
CN111346110A (zh) * 2020-03-17 2020-06-30 遵义医学院附属医院 间充质干细胞上清液在制备治疗肺细胞损伤制剂中的应用
WO2021216903A1 (en) * 2020-04-22 2021-10-28 Kenneth Allen Pettine Methods and compositions for treating inflammatory conditions associated with infectious disease
AU2021306640A1 (en) * 2020-07-09 2023-02-09 Exo Biologics Sa Process for the manufacturing of protein-associated extracellular vesicles
WO2022008657A1 (en) 2020-07-09 2022-01-13 Exo Biologics Sa Extracellular vesicles and compositions thereof
AU2021313472B2 (en) * 2020-07-20 2025-10-16 Brainstorm Cell Therapeutics Ltd. Methods and compositions for treating lung conditions
CN112043686A (zh) * 2020-09-21 2020-12-08 沈阳三禾生物科技有限公司 脐带间充质干细胞外泌体雾化液在制备治疗哮喘产品中的应用
CN112007049A (zh) * 2020-09-21 2020-12-01 济南磐升生物技术有限公司 一种用于治疗膝骨关节炎的干细胞外泌体组合物
JP2023547728A (ja) * 2020-11-06 2023-11-13 アーテック メディカル ジーエムビーエイチ 間葉系幹細胞由来の細胞外小胞およびアルファ-1アンチトリプシンを含むウイルス感染症治療用組成物
EP3995130A1 (en) * 2020-11-06 2022-05-11 JunctuCell Biomed Manufacturing GmbH A composition comprising extra-cellular vesicles from mesenchymal stem cells and alpha-1 antitrypsin for the treatment of viral infections
EP4252761A4 (en) * 2020-11-26 2024-06-05 Samsung Life Public Welfare Foundation COMPOSITION FOR THE TREATMENT OF INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-PROCESSED STEM CELLS
USD1046870S1 (en) 2020-12-08 2024-10-15 Samsung Electronics Co., Ltd. Accessory panel for television receiver
CN112675203A (zh) * 2021-02-08 2021-04-20 瑞太生物科技(沈阳)有限公司 一种细胞来源的外泌体在制备治疗哮喘和/或肺纤维化生物制剂中的应用
CN118369417A (zh) 2021-09-16 2024-07-19 生命技术公司 细胞扩增方法和其中使用的组合物
EP4501338A1 (en) 2022-03-28 2025-02-05 Hiroko Science Inc. Pharmaceutical composition containing mir-140 and method for producing same
CN115725499B (zh) * 2022-08-15 2025-08-15 哈尔滨医科大学 一种人脐带间充质干细胞膜仿生纳米囊泡的制备方法和应用
CN116897887A (zh) * 2023-07-31 2023-10-20 湖南中医药大学 一种病毒性哮喘动物模型的构建方法
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
WO2025250774A1 (en) * 2024-05-31 2025-12-04 Leksum LLC Extracellular vesicles for therapy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
FR2766205B1 (fr) * 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US20030221199A1 (en) * 1998-10-20 2003-11-27 Whitsett Jeffrey A. Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
US20040214783A1 (en) * 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
WO2006110582A1 (en) 2005-04-08 2006-10-19 Xcyte Therapies, Inc. Compositions and methods for the treatment of burns and sepsis
BRPI0617084A2 (pt) 2005-09-02 2011-07-12 Agency Science Tech & Res método, linhagem de célula progenitora, célula diferenciada e método para gerar uma célula diferenciada de uma célula-tronco (es) embrionária
US20090274665A1 (en) * 2006-04-27 2009-11-05 Cell Therapy Technologies, Inc. Stem Cells For Treating Lung Diseases
EP2054506A1 (en) 2006-08-15 2009-05-06 Agency for Science, Technology and Research Mesenchymal stem cell conditioned medium
EP2578081B1 (en) 2006-10-11 2016-03-09 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
CN102014934B (zh) 2008-02-22 2014-08-20 新加坡科技研究局 间充质干细胞颗粒
US20120107413A1 (en) * 2009-07-23 2012-05-03 Singapore Health Services Pte Ltd Pre-natal mesenchymal stem cells
SG2014010698A (en) 2009-11-02 2014-05-29 Agency Science Tech & Res Methods of monitoring cellular states
KR101189655B1 (ko) * 2010-06-30 2012-10-11 성균관대학교산학협력단 줄기세포 배양액을 포함하는 폐질환 치료용 조성물
CN101890050B (zh) * 2010-07-14 2012-07-04 江苏大学 脐带间质干细胞来源膜性囊泡及其应用
CN103210089A (zh) 2010-08-13 2013-07-17 格拉斯哥大学大学行政评议会 微泡和相关的微小rna的治疗用途
AU2012220872A1 (en) 2011-02-22 2013-09-12 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers
CN103648509B (zh) * 2011-03-11 2019-02-22 儿童医学中心公司 与间充质干细胞外来体相关的方法和组合物
ES2691296T3 (es) 2012-04-03 2018-11-26 Reneuron Limited Micropartículas de células madre
CN106714781B (zh) 2014-05-18 2021-08-10 儿童医学中心公司 涉及外排体的方法和组合物

Similar Documents

Publication Publication Date Title
JP2014507482A5 (enExample)
JP2015525757A5 (enExample)
JP2012500090A5 (enExample)
JP2013014622A5 (enExample)
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
MX2013004817A (es) Enfermedad inflamatoria.
LT4104824T (lt) Kompozicijos, skirtos panaudoti taikant pacientams su didele širdies ir kraujagyslių ligos rizika antsvorio ir nutukimo gydymo būdą
BR112014011981A8 (pt) Formulações farmacêuticas sólidas orais, seus processos de preparação e usos
JP2016014009A5 (enExample)
JP2013523758A5 (enExample)
JP2019528267A5 (enExample)
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof
WO2014164280A8 (en) Micronized pharmaceutical compositions
JP2015536999A5 (enExample)
TR200909788A2 (tr) Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
TR200907913A2 (tr) İnhalason yolu ile alınmak üzere kuru toz formunda farmasötik bileşim
JP2013509443A5 (enExample)
MY179215A (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
TR200907915A2 (tr) Kuru toz formunda farmasötik bileşim.
TR201004317A2 (tr) Türbülans oluşumunu sağlayan inhalasyon cihazı.
Patterson et al. Effect Of Injured Lung Derived Inflammatory Mediators On Peripheral Organ Cells
WO2013109213A3 (en) Pharmaceutical formulations comprising tiotropium
CN302371352S (zh) 一次性使用人体酒精测试仪(2)
CN301973213S (zh) 椅子(gs-g1795b)
CN302243804S (zh) 游艺机(超级秋千)